D’Ascenzi F, Adami PA, Eichler S, et al. The Young Community of the European Association of Preventive Cardiology: the future in motion. Eur J Prev Cardiol 2018; 25: 567–568.
2.
PiepoliMF. We are standing on the shoulders of giants. The European Journal of Preventive Cardiology in the years to come: a salutation from the incoming editor-in-chief. Eur J Prev Cardiol2017; 24: 564–566.
3.
SchieleFEcarnotFChopardR. Coronary artery disease: risk stratification and patient selection for more aggressive secondary prevention. Eur J Prev Cardiol2017; 24(3 Suppl): 88–100.
4.
Colombo MG, Kirchberger I, Amann U, et al. Association of serum potassium concentration with mortality and ventricular arrhythmias in patients with acute myocardial infarction: a systematic review and meta-analysis. Eur J Prev Cardiol 2018; 25: 576–595.
5.
Guerra F and Capucci A. Serum potassium and acute coronary syndrome: in medio stat virtus. Eur J Prev Cardiol 2018; 25: 574–575.
6.
Batty GD, Jung KJ, Mok Y, et al. Oral health and later coronary heart disease: cohort study of one million people. Eur J Prev Cardiol 2018; 25: 598–605.
7.
VeronesiGTunstall-PedoeHFerrarioMMet al.Combined effect of educational status and cardiovascular risk factors on the incidence of coronary heart disease and stroke in European cohorts: implications for prevention. Eur J Prev Cardiol2017; 24: 437–445.
8.
WangHLiYWangXet al.Endogenous sex hormone levels and coronary heart disease risk in postmenopausal women: a meta-analysis of prospective studies. Eur J Prev Cardiol2017; 24: 600–611.
9.
D’Souza M, Carlson N, Fosbøl E, et al. CHA2DS2-VASc score and risk of thromboembolism and bleeding in patients with atrial fibrillation and recent cancer. Eur J Prev Cardiol 25: 651–658.
10.
MazzoneCCioffiGCarriereCet al.Predictive role of CHA2DS2-VASc score for cardiovascular events and death in patients with arterial hypertension and stable sinus rhythm. Eur J Prev Cardiol2017; 24: 1584–1593.
11.
CohenGLevyIYuvalet al.Long-term exposure to traffic-related air pollution and cancer among survivors of myocardial infarction: a 20-year follow-up study. Eur J Prev Cardiol2017; 24: 92–102.
12.
Cohen G, Levy I, Yuval, et al. Chronic exposure to traffic-related air pollution and cancer incidence among 10,000 patients undergoing percutaneous coronary interventions: a historical prospective study. Eur J Prev Cardiol 2018; 25: 659–670.
13.
VigoritoCAbreuAAmbrosettiMet al.Frailty and cardiac rehabilitation: a call to action from the Cardiac Rehabilitation Section. Eur J Prev Cardiol2017; 24: 577–590.
14.
EichlerSSalzwedelAReibisRet al.Multicomponent cardiac rehabilitation in patients after transcatheter aortic valve implantation: predictors of functional and psychocognitive recovery. Eur J Prev Cardiol2017; 24: 257–264.
15.
RibeiroGSMeloRDDereszLFet al.Cardiac rehabilitation programme after transcatheter aortic valve implantation versus surgical aortic valve replacement: systematic review and meta-analysis. Eur J Prev Cardiol2017; 24: 688–697.
16.
RuddoxVSandvenIMunkhaugenJet al.Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: a systematic review and meta-analysis. Eur J Prev Cardiol2017; 24: 1555–1566.
17.
GorenekBPellicciaABenjaminEJet al.European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). Eur J Prev Cardiol2017; 24: 4–40.
18.
Morseth B, Løchen ML, Ariansen I, et al. The ambiguity of physical activity, exercise and atrial fibrillation. Eur J Prev Cardiol 25: 624–636.
19.
SkielboeAKMarottJLDixenUet al.Occupational physical activity, but not leisure-time physical activity increases the risk of atrial fibrillation: the Copenhagen City Heart Study. Eur J Prev Cardiol2016; 23: 1883–1893.
20.
PiepoliMFHoesAWAgewallSet al.European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur J Prev Cardiol2016; 23: NP1–NP96.
21.
BalderJWde VriesJKMulderDJet al.Time to improve statin prescription guidelines in low-risk patients?Eur J Prev Cardiol2017; 24: 1064–1070.
22.
Lagerweij GR, de Wit GA, Moons KG, et al. A new selection method to increase the health benefits of CVD prevention strategies. Eur J Prev Cardiol 2018; 25: 642–650.
